BackRevelation Biosciences Overview

Revelation Biosciences Net Tangible Assets

Track Revelation Biosciences's net tangible assets ($13M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$12.99M

Peer average

Loading

Revelation Biosciences Net Tangible Assets History

Loading

Revelation Biosciences vs. peers: Net Tangible Assets Comparison

Loading

Revelation Biosciences Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Revelation Biosciences (REVB) FAQ

Revelation Biosciences posts a net tangible assets of $13M as of March 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Revelation Biosciences's net tangible assets was $0. The latest reading is $13M (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Net Tangible Assets is one piece of Revelation Biosciences's financial statement story. At $13M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for REVB's net tangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Revelation Biosciences's other metric pages and overview cover the third.